MPC2 Overexpression Drives Mitochondrial Oxidative Phosphorylation and Promotes Progression in Diffuse Large B-Cell...

Area of Science:

• Oncology
• Metabolic pathways
• Mitochondrial biology

Background:

• Diffuse Large B-Cell Lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma with poorly understood metabolic drivers.
• Mitochondrial dysfunction is implicated in cancer, but its specific role in DLBCL progression is unclear.

Purpose of the Study:

• To identify key mitochondrial factors regulating DLBCL progression.
• To investigate the role of Mitochondrial Pyruvate Carrier 2 (MPC2) in DLBCL pathogenesis.

Main Methods:

• Analysis of multiple DLBCL transcriptomic datasets using differential expression, WGCNA, and GSEA.
• Validation of MPC2 expression and function in clinical samples, cell lines, and xenograft models.
• Functional assays including knockdown of MPC2 to assess impact on cell metabolism and tumor growth.

Main Results:

• MPC2 was identified as a significantly upregulated gene in DLBCL, linked to oxidative phosphorylation (OXPHOS) and cell cycle pathways.
• MPC2 overexpression was confirmed at mRNA and protein levels in DLBCL samples and cell lines.
• MPC2 knockdown impaired OXPHOS, increased glycolysis, and suppressed DLBCL cell proliferation, invasion, and tumor growth in vivo.

Conclusions:

• MPC2 is a key regulator of mitochondrial metabolism in DLBCL, promoting tumor progression via enhanced OXPHOS.
• These findings highlight MPC2 as a potential therapeutic target for DLBCL.